1055329-47-9
1055329-47-9
Chemical Structure
Sutherlandioside B
- CAS No.: 1055329-47-9
- Formula:C36H60O10
- Molecular Weight:652.86
InChIKey: TZQVQOSZDDCXGL-BRSOWDSUSA-N
SMILES: O=C1[C@]23[C@@]4(C3)[C@]([C@H](C[C@@]2([H])C(C)([C@@H](C1)O)C)O)([H])[C@]5([C@](CC4)([C@@](CC5)([H])[C@H](C)CC[C@H](O)C(C)(C)O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O)CO)C)C
Biological Activity: Sutherlandioside B is an antioxidant. Sutherlandioside B reduces the production of reactive oxygen species (ROS). Sutherlandioside B exhibits antiviral activity. Sutherlandioside B can be used in studies related to viral infections[1][2][3][4][5].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sutherlandioside B | Sutherlandioside B is an antioxidant. Sutherlandioside B reduces the production of reactive oxygen species (ROS). Sutherlandioside B exhibits antiviral activity. Sutherlandioside B can be used in studies related to viral infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Brownstein KJ, et al. Isolation of Sutherlandioside B from Sutherlandia frutescens by Spiral Countercurrent Chromatography. J Liq Chromatogr Relat Technol. 2015;38(4):423-429.
- [2]. Fu X. Phytochemical studies on the medicinal plant Sutherlandia frutescens [dissertation]. University (MS): University of Mississippi; 2012 Jan.
- [3]. Lei W, et al. Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages. International immunopharmacology. 2015 Dec;29(2):254-262.
- [4]. Chen L, et al. Comparative cardio and developmental toxicity induced by the popular medicinal extract of Sutherlandia frutescens (L.) R.Br. detected using a zebrafish Tuebingen embryo model. BMC complementary and alternative medicine. 2018 Oct 05;18(1):273.
- [5]. Avula B, et al. Quantitative determination of flavonoids and cycloartanol glycosides from aerial parts of Sutherlandia frutescens (L.) R. BR. by using LC-UV/ELSD methods and confirmation by using LC-MS method. J Pharm Biomed Anal. 2010 Jun 5;52(2):173-80.
Keywords
